Conformationally Constrained ortho-Anilino Diaryl Ureas: Discovery of 1-(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y₁ Antagonist

Citations Over TimeTop 10% of 2013 papers

Abstract

Preclinical antithrombotic efficacy and bleeding models have demonstrated that P2Y1 antagonists are efficacious as antiplatelet agents and may offer a safety advantage over P2Y12 antagonists in terms of reduced bleeding liabilities. In this article, we describe the structural modification of the tert-butyl phenoxy portion of lead compound 1 and the subsequent discovery of a novel series of conformationally constrained ortho-anilino diaryl ureas. In particular, spiropiperidine indoline-substituted diaryl ureas are described as potent, orally bioavailable small-molecule P2Y1 antagonists with improved activity in functional assays and improved oral bioavailability in rats. Homology modeling and rat PK/PD studies on benchmark compound 3l will also be presented. Compound 3l was our first P2Y1 antagonist to demonstrate a robust oral antithrombotic effect with mild bleeding liability in the rat thrombosis and hemostasis models.

Related Papers

• → Gold(I)-Catalyzed Substitution-Controlled Syntheses of Spiro[indoline-3,3′-pyrrolidine] and Spiro[indoline-3,3′-piperidine] Derivatives(2023)7 cited
• → Convenient synthesis of 1,1′-H-spiro[indoline-3,3′-piperidine](2008)15 cited
• → A convenient synthesis of 1′-H-spiro-(indoline-3,4′-piperidine) and its derivatives(2004)18 cited
• Synthesis of 1'-Boc-5-fluoro-spiro-(indoline-3,4'-piperidine)(2009)
• → A Convenient Synthesis of 1′‐H‐Spiro‐(indoline‐3,4′‐piperidine) and Its Derivatives.(2004)